A post-hoc analysis of the pivotal CANVAS trial shows those receiving higher dose canagliflozin are more likely to experience the cardiovascular benefits associated with the drug.

A cheap over-the-counter supplement could hold the key to preventing heart failure in people with Type 2 diabetes, according ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

The researchers discovered that after just six months of use, patients had double the risk of developing neovascular ...

A newly published randomized controlled trial in Frontiers in Medicine has found that the practice of Transcendental ...

Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

Apple cider vinegar can cause side effects when taking it and certain medications. Learn which medications apple cider ...

Are you tired of boring dieting and gruesome workouts? Then, medical weight loss treatment can be a solution for you. But ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...